MannKind (MNKD) Company Cash Volume

Brandmark of mannkindcorp.com (MNKD)

MannKind Corporation occupies a unique niche by developing painless inhalable insulin delivery systems. The company's cash history demonstrates financial resilience, while 0.10 records a new level mark. The business relies on external distribution coupled with in-house production, and stable royalty payments for hypertension medications provide a liquidity inflow that supports current development.

Company Cash and Cash Equivalents: MannKind Corp (MNKD) for 07/04/2022 - 11/21/2026

Financial and market metric breakdowns for MannKind (MNKD)

- stock value and consensus price forecast:
Fundamental company analysis:MNKD MannKind Corp
Product sample of mannkindcorp.com

Total cash holdings determine the company's liquid safety margin, allowing for an assessment of its resilience to macroeconomic shocks. By analyzing the cash flow chart, an investor can see the balance between financial protection and the risk of inflationary asset depreciation, which is critical for MannKind Corporation (MNKD) when monetizing patents for its unique inhaled insulin and implementing a premium pricing strategy.

Competitors of MannKind Corporation (MNKD)

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|AMPH (Amphastar Corp) - Company Cash Balance|Company Cash Funds pacira.com PCRX|SPRY - Company Cash on Hand|Theravance Biopharma, Inc. - Company Cash Volume|Company Cash Balance AQST (Aquestive Therapeutics, Inc.)|SCPH: Company Cash Volume|Tectonic Therapeutic Inc. - Company Cash Balance|TNXP (Tonix Pharma) - Company Cash Volume|SXTC: Company Cash Balance|Company Cash Volume EPRX|BHST - Company Cash Reserve|eXoZymes - Company Cash on Hand|Company Cash Volume oramed.com ORMP|ENTX - Company Cash Funds|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance